Vitreous Hemorrhage Clinical Trials

A listing of Vitreous Hemorrhage medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Campbell California 95008

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Glendale California 91203

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Huntington Beach California 92647

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Loma Linda California 92354

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Porterville California 93257

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Florida

Lakeland Florida 33805

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Pinellas Park Florida 33782

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Sarasota Florida 34233

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Tampa Florida 33609

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Augusta Georgia 30909

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Marietta Georgia 30060

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Sandy Springs Georgia 30328

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Illinois

Bloomington Illinois 61704

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Chicago Illinois 60612

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Chicago Illinois 60611

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Urbana Illinois 61801

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Indiana

Indianapolis Indiana 42690

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

New Albany Indiana 47150

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Kansas

Shawnee Mission Kansas 66204

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Kentucky

Paducah Kentucky 42001

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Louisiana

West Monroe Louisiana 71291

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Maryland

Baltimore Maryland 21237

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Baltimore Maryland 21287

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Massachusetts

Ayer Massachusetts 01432

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Boston Massachusetts 02215

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Michigan

Ann Arbor Michigan 48105

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Detroit Michigan 48202

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Grand Rapids Michigan 49546

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Minnesota

Minneapolis Minnesota 55404

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Rochester Minnesota 55905

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Missouri

Kansas City Missouri 64111

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

St. Louis Missouri 63128

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

New York

New York New York 10021

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

New York New York 10003

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

New York New York 10021

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Syracuse New York 13224

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

North Carolina

Chapel Hill North Carolina 27517

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Charlotte North Carolina 28210

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Ohio

Beachwood Ohio 44122

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Cleveland Ohio 44106

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Oklahoma

Edmond Oklahoma 73013

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Oklahoma City Oklahoma 73104

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Oregon

Eugene Oregon 97401

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Portland Oregon 97239

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Portland Oregon 97221

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Pennsylvania

Monroeville Pennsylvania 15146

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

South Carolina

West Columbia South Carolina 29169

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Tennessee

Chattanooga Tennessee 37421

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage

Knoxville Tennessee 37909

A clinical trial to evaluate treatments using 2-mg Intravitreous Aflibercept Injection and Prompt Vitrectomy Plus Panretinal Photocoagulation for patients with Proliferative Diabetic Retinopathy or Vitreous Hemorrhage